ClinicalTrials.Veeva

Menu

Bronchial Blocker for One-lung Ventilation in Cardiac Surgery

A

Air Force Military Medical University of People's Liberation Army

Status and phase

Unknown
Phase 4

Conditions

Postoperative; Dysfunction Following Cardiac Surgery
Intubation Complication
Complication of Ventilation Therapy

Treatments

Device: double-lumen endotracheal tube (DLT group)
Device: endobronchial blocker (BB group)

Study type

Interventional

Funder types

Other

Identifiers

NCT02729610
KY20153001-1

Details and patient eligibility

About

To investigate if bronchial blocker is more suitable for one-lung ventilation during thoracoscope assisted mitral valve replacement surgery with Cardiopulmonary Bypass than the double-lumen endobronchial tube.

Full description

Postoperative hoarseness, sore throat, and vocal cord injuries are common complications after general anesthesia. The incidence of postoperative hoarseness is as frequent as 50% after short-term tracheal intubation. In the past, several risk factors for postoperative hoarseness and laryngeal injury have been identified, including demographic factors, quality of tracheal intubation and technical factors such as endotracheal tube size. One-lung ventilation during thoracotomy can be achieved via two basic techniques: (1) use of a double-lumen endotracheal tube (DLT) consisting of an endotracheal and an endobronchial lumen allowing independent single-lung ventilation ; or (2) use of an endobronchial blocker such as the Arndt blocker, which allows lung collapse distal to the occlusion. It has been recently demonstrated that DLT and endobronchial blocker are similar in their efficacy to achieve lung isolation for elective thoracic surgery. No data are available yet about the influence of the chosen technique on postoperative hoarseness, vocal cord injuries, sore throat, and bronchial injuries. Published data of Stout et al. imply that the incidence of postoperative hoarseness and vocal cord injury might be directly correlated with size of the used endotracheal tube. During thoracoscope assisted mitral valve replacement cardiac surgery, excellent lung isolated was not required. One-lung ventilation with the other lung collapsed is used to achieve a better exposure and assist the surgery. During the cardiac surgery under cardiopulmonary bypass, heparinization will lead to uncontrolled hemorrhage if there is endotracheal tube insertion associated injury. In addition, DLTs need to be exchanged for a single-lumen tube before the patient transferring to cardiac care unit for postoperative ventilatory support. This may result in second time injury. Investigators hypothesized that using a bronchial blocker to achieve one-lung ventilation may result in a lower incidence of clinically relevant laryngeal and bronchial morbidity after thoracoscope assisted mitral valve replacement cardiac surgery compared with a control group intubated with a DLT.

Enrollment

58 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. New York Heart Association (NYHA)I-III level.
  2. scheduled for thoracoscope assisted mitral valve surgery under surgery
  3. provide with informed consent.

Exclusion criteria

  1. emergency surgery.
  2. preoperative pulmonary diseases, such as chronic obstructive pulmonary disease, atelectasis.
  3. preoperative voice hoarse or sore throat.
  4. involved in other clinical trials within 3 months .
  5. Cannot cooperate with language understanding disorders or psychological problems.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

58 participants in 2 patient groups

DLT group
Active Comparator group
Description:
In this arm, patient will be intubated with a double lumen endotracheal tube
Treatment:
Device: double-lumen endotracheal tube (DLT group)
BB group
Experimental group
Description:
In this arm, patient will be intubated with an endobronchial blocker
Treatment:
Device: endobronchial blocker (BB group)

Trial contacts and locations

0

Loading...

Central trial contact

Chong Lei, MD & PhD; Hailong Dong, MD & PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems